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Paralysis periodica paramyotonica
Paralysis periodica paramyotonica is an overlapping disease that shares the features of paramyotonia
characteristic of paramyotonia congenita (PC) and periodic paralysis characteristic of hyperkalemic periodic
paralysis. We report the case of a 23-year-old man with paralysis periodica paramyotonica. His father and a
younger brother also exhibited a similar phenotype. A SCN4A Arg1448Cys mutation was detected in this
family. The affected family members exhibited marked shifts in compound muscle action potential amplitudes
on exercise test, and muscle weakness could be induced by potassium loading and cold exposure. This case
demonstrates that SCN4A Arg1448Cys can produce paralysis periodica paramyotonica. Other genetic or
environmental factors may modulate the manifestation of SCN4A Arg1448Cys mutation. [J Formos Med Assoc
2006;105(6):503–507]
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Mutations in the skeletal muscle sodium chan-
nel gene SCN4A have been reported to cause three
clinically distinct diseases: paramyotonia con-
genita (PC), hyperkalemic periodic paralysis
(HyperKPP) and potassium aggravated myoto-
nia (PAM). Potassium sensitivity is the main char-
acteristic of HyperKPP, but it is not observed in
PC. Conversely, myotonia induced by exposure
to cold or exercise, so called paramyotonia, is pre-
sent in PC but not always present in HyperKPP.1
In addition to these well-characterized disorders,
an overlapping disease called paralysis periodica
paramyotonica has been reported sporadically
and in patients with a familial history of PC or
HyperKPP.2–4 Paralysis periodica paramyotonica
encompasses the features of PC-like paramyoto-
nia and HyperKPP-like periodic paralysis.
These clinically distinct diseases are caused by
sodium channel defects and different mutations
have been reported for certain phenotypes. For
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example, HyperKPP has been reported with the
missense mutations Thr704Met and Met1592Val,
PC with Thr1313Met and Arg1448His, and PAM
with Ser804Phe and Ile1160Val.5 The close rela-
tionship between genotype and phenotype sug-
gests that a specific mutation in the sodium chan-
nel may lead to a unique phenotype. However,
there is growing evidence to suggest that the re-
lationship between genotype and phenotype is
not always so clear.2–4,6–8 Missense mutations at
the 1448th amino acid of the SCN4A gene, e.g.
Arg1448His or Arg1448Cys, are established as a
cause of pure PC. In contrast, Arg1448His and
Arg1448Cys mutations causing paralysis periodi-
ca paramyotonica have each been reported only
once.9,10 We report a Taiwanese family with homo-
geneous phenotype of paralysis periodica para-
myotonica. Genetic analysis showed that this over-
lapping syndrome was caused by a Arg1448Cys
mutation in the SCN4A gene, which has been re-
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sium loading test and a cold provocation test, were
performed. The tests were given on three separate
days to allow sufficient recovery to avoid inter-
ference. Routine nerve conduction test and elec-
tromyography were performed at room tempera-
ture. The exercise test was performed according
to the protocols described by McManis et al.11
Baseline serum potassium level was checked and
hand grasping power was measured with a dy-
namometer before the potassium loading test.
After ingestion of 40 mmol of potassium chloride,
serum potassium levels and grasping power were
measured every 30 minutes. A cold provocation
test was performed by placing the right hand in
ice water at 10°C for 30 minutes. Myotonia and
muscle weakness were checked 5, 10, 15 and
30 minutes after cold exposure to observe the re-
covery of muscle strength.
Genetic analysis
Genetic studies were performed on peripheral
blood leukocyte-derived DNA samples from each
of three symptomatic family members and an
unaffected sibling of the proband. Total cellular
DNA was isolated using a modified proteinase K
digestion method. The exons of the SCN4A gene
were amplified using intronic primer pairs in
polymerase chain reactions (PCR). The primer
pairs were chosen to cover mutation hot spots.
The exons amplified and the base sequence of
the primers are shown in the Table. PCR was per-
formed with a denaturing condition of 94°C for
20 seconds, an annealing condition of 58°C for
30 seconds and an extension condition of 72°C
for 15 seconds, for a total of 35 cycles. PCR prod-
ucts were subjected to direct DNA sequencing.
The results were compared with the published
SCNA sequence (GenBank AY212253.1).
Results
All four of the members in the family who were
studied underwent conventional nerve conduc-
tion tests, exercise tests and genetic tests. The
proband (II-1 in the pedigree) and his affected
ported to cause pure paramyotonia phenotype.
This finding further confirms that the 1448th ami-
no acid in the SCN4A gene is the hotspot for this
overlapping syndrome.
Methods
Patients
A 23-year-old man had a history of cold-induced
stiffness and weakness since the age of 14 years.
He described the history of these manifestations
as beginning with an attack of muscle weakness
and stiffness in all four limbs that persisted for
4–5 hours during a cold winter night when he
was 14 years old. Similar attacks then occurred 3–
4 times a month, triggered by cold conditions,
hunger and certain chicken-based soups. Attacks
were also triggered by rest after exercise and were
alleviated by resumption of mild exercise. The fre-
quency of attacks gradually decreased with age
and was reduced to once or twice a month during
his twenties. Neurologic assessment revealed nor-
mal motor, sensory and muscle status. Percussion
myotonia in the thenar eminence and tongue were
absent. His father and one of his younger brothers
had similar symptoms of periodic paralysis and
cold-induced focal myotonia of the face and hands.
Another younger brother was free from attacks. The
family pedigree is shown in Figure 1.
Provocation tests
Three provocation tests, an exercise test, a potas-
Figure 1. Family pedigree. The black symbols represent affected
individuals as diagnosed by genetic tests. Affected family members
as determined by phenotypic history are indicated by gray symbols.
The proband is indicated by an arrow.
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younger brother (II-3) underwent electromyo-
graphy, potassium loading and cold provocation
tests. Conventional nerve conduction studies were
normal in all tested family members. Electromyo-
graphy showed electrical myotonic discharge in
the proband and his affected brother. The results
of the exercise tests are summarized in Figure 2.
The proband had a mean compound muscle ac-
tion potential (CMAP) of 9.1 mV at baseline. Five
minutes after exercise, the amplitude had in-
creased 40.7% to 12.8 mV, and 33 minutes after
this initial increase, the amplitude had dropped
60.2% to 5.1 mV. Similar CMAP amplitude changes
during and after exercise were observed in the
proband’s father (I-1). However, while the proband
and his father exhibited increased CMAP ampli-
tude during exercise followed by a gradual de-
crement after exercise, the CMAP amplitude in
the affected brother decreased rapidly by 67.7%
from 13.3 mV to 4.3 mV immediately following
exercise. The unaffected younger brother (II-2)
did not show any major shifts in CMAP amplitude
with the exercise test.
The proband’s baseline serum potassium level
was 4.3 mmol/L, and his baseline grasping power
determined by dynamometer was 40 kg. Two hours
after potassium loading, his serum potassium
level had increased to 5.8 mmol/L and his grasp-
ing power had decreased to 29 kg. The cold provo-
cation test also revealed focal weakness and myo-
tonia. Weakness induced by potassium loading
and focal myotonia induced by cold water test were
also seen in the affected brother.
Molecular analyses of the SCN4A sodium chan-
nel gene revealed a heterozygous C-to-T transition
at position 4342. This mutation resulted in a sub-
stitution of a Cys for an Arg residue at codon 1448
in all three affected family members (Figure 3A).
This mutation was not found in the non-affected
younger brother (Figure 3B).
Discussion
The proband (II-1) and his affected brother (II-
3) exhibited characteristics of both potassium-
sensitive periodic paralysis and paradoxical myo-
tonia. The potassium loading test was used to
document the former condition, the hallmark of
HyperKPP. Cold-induced stiffness, weakness and
myotonia confirmed the latter condition. These
findings indicated a diagnosis of paralysis perio-
dica paramyotonica. Genetic study revealed an
Arg1448Cys mutation in the sodium channel gene
in the affected members of this family (I-1, II-1, II-
3), but not in one unaffected family member (II-
2). According to the pedigree shown in Figure 1,
the hereditary transmission mode in this family is
autosomal dominant.
Exercise testing is useful in confirming calcium
and sodium channelopathies and thyrotoxic peri-
Table. Exons amplified and the base sequence of the primers
for polymerase chain reaction
Exon amplified Primer sequence Amplicon size (bp)
Exon 13 CTCATTCACCCTTGCCCTCC 438
TTGTACGCTTCCCGGGTGAG
Exon 19 GAGAGGCACTGGCAATGGAC 354
CTCCATCCAGGTTCCCGGCA
Exon 23 TCAGTGCTGCCCTGCCGGTC 330
TCCACTCCCACCCATGCTGC
Exon 24 GCGTCCTCACTAGCTTCTCC 548
CCACATTGAAGTTCTCCAGG
Figure 2. Exercise test results. The proband (II-1) and his father (I-1) exhibited an
increase in compound muscle action potential (CMAP) amplitude immediately after
exercise, followed by a decrease in amplitude. The affected younger brother of the
proband (II-3) exhibited a different pattern of no increase in amplitude followed by a
rapidly decreasing amplitude. The unaffected younger brother of the proband (II-2) did
not exhibit a CMAP amplitude shift during exercise test.
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odic paralysis.12 The response pattern of exercise
test most often reported in patients with paralysis
periodica paramyotonica is an increase in CMAP
amplitude during or immediately after exercise,
followed by an abnormal gradual decrement. The
proband in this family showed a 40.7% CMAP
amplitude increment during exercise, followed
by a 62.2% decrement. His father showed a simi-
lar post-exercise CMAP response pattern.
Two other exercise test response patterns have
been found in patients with paralysis periodica
paramyotonica. The first is a lack of observable
CMAP amplitude increase during exercise fol-
lowed by a marked rather than gradual decre-
ment. This response pattern was observed in the
affected younger brother (II-3) of the proband in
this family and is characteristic of PC.12 The other
response pattern is a lack of observable CMAP
amplitude increase during exercise followed by
a gradual decrease in CMAP after exercise. This
response pattern was reported in a patient with
HyperKPP/PC overlapping syndrome.2
Seven mutation loci in the SCN4A gene have
been linked to paralysis periodica paramyo-
tonica.3,4,6–10 Four mutations were originally de-
scribed in HyperKPP (Thr704Met, Met1592Val,
Ala1156Thr, Met1360Val) and two in PC
(Arg1448Cys, Arg1448His). Members of fami-
lies with these mutations present with various
clinical manifestations. For example, PC, Hyper-
KPP and paralysis periodica paramyotonica were
found in different members of two families.8,9 Gen-
der-related modifications of phenotypic expres-
sion were also reported in two families with
Met1360Val and Met1370Val mutations.3,8 How-
ever, these gender-related modifications have
not been observed in other families with various
phenotypes.6,7 Four males in the family studied
here were assessed, and the affected members pre-
sented with features of both PC and HyperKPP.
The Arg1448Cys mutation was originally reported
to cause pure PC. However, it produced an over-
lapping syndrome in this family, indicating that
other genetic or environmental factors may mod-
ulate the manifestation of sodium channel dis-
orders. The most common functional change for
HyperKPP/PC mutants is an impairment of fast
activation of sodium channel.13 It has been hypo-
thesized that a modifying gene may affect the
expression of a sodium channel mutation, which
may explain the clinical variability in the SCN4A
mutation. Different phenotypes within the same
families suggest the effect of a modifying gene
closely linked to the sodium channel gene, or of a
polymorphism in the sodium channel gene itself.9
Only two Asian families with paralysis perio-
dica paramyotonica have been previously report-
ed. The disease was caused by a point mutation of
Thr704Met in a Korean family, although this mu-
tation had been originally reported to cause Hy-
perKPP only.4 A Japanese family was found to
have a novel mutation at Met1370Val.3 The pre-
sent Taiwanese family is the first reported Asian
family with an Arg1488Cys mutation resulting in
the paralysis periodica paramyotonica phenotype.
Our findings support that HyperKPP and PC can
be caused by a single genetic disorder, and are
consistent with previous data indicating that the
1448th amino acid coded for by the SCN4A gene is
a hotspot for this overlapping disease.
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